Aug 30, 2026•1 min read
MFDS Issues Draft Amendment Order for Opicapone Oral Formulations to Update Adverse Reaction Precautions
The Korean Ministry of Food and Drug Safety has prepared a draft amendment order for Opicapone oral drugs, revising the adverse‑reaction warnings and opening a public comment period.